In a 65‑year‑old woman taking methocarbamol 500 mg three times daily who reports severe headaches, what alternative or additional medication can be used to relieve her headaches?

Discontinue Methocarbamol and Treat the Headaches as Migraine

Your 65-year-old patient is experiencing headaches as a known adverse effect of methocarbamol 1, and you should stop this medication while initiating appropriate migraine treatment starting with NSAIDs or acetaminophen, escalating to triptans if needed.

Understanding the Problem

Headache is a documented adverse reaction to methocarbamol 1. At 65 years old, your patient requires careful consideration of both cardiovascular risk factors and medication tolerability when selecting headache treatment.

Immediate Action: Stop the Offending Agent

• Discontinue methocarbamol - The temporal relationship between taking this muscle relaxant and developing "terrible headaches" strongly suggests drug-induced headache
• Consider alternative muscle relaxants if the original indication still requires treatment
• The headaches may resolve with discontinuation alone

Treating the Headaches: Evidence-Based Approach

First-Line Treatment (Mild to Moderate Headaches)

Start with NSAIDs or acetaminophen 2:

• Ibuprofen 400-800 mg (up to 3200 mg/day maximum)
• Naproxen 500-550 mg (up to 1250 mg/day)
• Acetaminophen 1000 mg (up to 4000 mg/day)
• Can combine NSAID + acetaminophen for enhanced efficacy

Critical consideration at age 65: Assess cardiovascular risk factors, renal function, and GI bleeding risk before prescribing NSAIDs 3. If significant cardiovascular disease exists, acetaminophen is safer.

Second-Line Treatment (Moderate to Severe Headaches)

If first-line therapy fails after adequate dosing, add a triptan 2:

• Sumatriptan 50-100 mg (most evidence, lowest cost)
• Rizatriptan 10 mg (rapid onset)
• Eletriptan 40 mg (high efficacy)

Combine triptan + NSAID or acetaminophen for optimal efficacy 2

Age-specific caution: Screen for uncontrolled hypertension, coronary artery disease, cerebrovascular disease, and peripheral vascular disease before prescribing triptans 3. Triptans are contraindicated in patients with significant vascular disease.

Third-Line Options (If Triptans Fail or Are Contraindicated)

For patients who cannot tolerate or fail combination therapy 2:

• CGRP antagonists (gepants): Rimegepant 75 mg, ubrogepant 50-100 mg, or zavegepant nasal spray
• These have no vasoconstrictive effects, making them safer in patients with cardiovascular disease
• Lasmiditan 50-100 mg (ditan class) - last resort option, causes significant drowsiness

Regarding Tizanidine

You mentioned "li etizadine" (likely tizanidine). Do not substitute tizanidine for methocarbamol if the goal is to treat headaches. Tizanidine is another muscle relaxant and will not address migraine pathophysiology. Focus on migraine-specific or migraine-appropriate treatments outlined above.

Critical Warnings

• Avoid opioids and butalbital - explicitly not recommended for migraine treatment 2
• Monitor for medication-overuse headache: Limit acute treatment to <10 days/month for triptans, <15 days/month for NSAIDs 2
• Assess kidney function before NSAIDs given her age 3
• Check blood pressure before triptans

If Headaches Persist or Occur Frequently

Consider preventive therapy if headaches occur >4 days/month after stopping methocarbamol 4:

• Topiramate, valproate, or memantine
• CGRP monoclonal antibodies (fremanezumab, galcanezumab, erenumab)
• Lisinopril or angiotensin-receptor blockers

Practical Algorithm

1. Stop methocarbamol immediately
2. Assess cardiovascular risk (BP, CAD, stroke history, PAD)
3. If low CV risk: Start ibuprofen 600 mg + acetaminophen 1000 mg at headache onset
4. If inadequate response after 2-3 headaches: Add sumatriptan 100 mg to the NSAID/acetaminophen
5. If high CV risk or triptan contraindicated: Use acetaminophen alone initially, then add gepant (rimegepant or ubrogepant)
6. If headaches continue >4 days/month: Initiate preventive therapy